药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Nitroxoline
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium carbonate
Magnesium carbonate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium trisilicate
Magnesium trisilicate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium
Sodium phosphate, monobasic can cause a decrease in the absorption of Magnesium resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium citrate
Magnesium citrate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium lactate
Magnesium lactate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium levulinate
Magnesium levulinate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium orotate
Magnesium orotate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium gluconate
Magnesium gluconate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magnesium aspartate
Magnesium aspartate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Magaldrate
Magaldrate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Loxoprofen
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Loxoprofen.
Nitroxoline
Flurbiprofen axetil
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Flurbiprofen axetil.
Nitroxoline
NS-398
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with NS-398.
Nitroxoline
SC-236
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with SC-236.
Nitroxoline
Imidazole salicylate
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Imidazole salicylate.